Trial Profile
A pilot study of sofosbuvir/ledipasvirn in 6- to 12- year old children with chronic HCV genotype 4 infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 03 May 2018 New trial record
- 25 Apr 2018 Results published in the Alimentary Pharmacology and Therapeutics